Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Essa Y Baitei

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bone|October 20, 2012
Novel and de novo PHEX mutations in patients with hypophosphatemic ricketsErdem Durmaz, Minjing Zou, Roua A Al-Rijjal, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinomaMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2010
Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinomaHussein Raef, Roua Al-Rijjal, Sameerah Al-Shehri, et al.
Cancer Research|March 1, 2017
<i>Cyp24a1</i> Attenuation Limits Progression of <i>Braf<sup>V600E</sup></i> -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAF<sup>V600E</sup> Inhibitor PLX4720Minjing Zou, Essa Y Baitei, Huda A BinEssa, et al.
Clinical Endocrinology|June 2, 2011
A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotypeHussein Raef, Minjing Zou, Essa Y Baitei, et al.
Clinical Endocrinology|April 7, 2017
Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic ricketsAyla Guven, Roua A Al-Rijjal, Huda A BinEssa, et al.
Clinical Endocrinology|October 25, 2011
Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistanceAli S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 7, 2015
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1Minjing Zou, Essa Y Baitei, Roua A Al-Rijjal, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2018
Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid DyshormonogenesisMinjing Zou, Ali S Alzahrani, Ali Al-Odaib, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bone|October 20, 2012
Novel and de novo PHEX mutations in patients with hypophosphatemic ricketsErdem Durmaz, Minjing Zou, Roua A Al-Rijjal, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinomaMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2010
Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinomaHussein Raef, Roua Al-Rijjal, Sameerah Al-Shehri, et al.
Cancer Research|March 1, 2017
<i>Cyp24a1</i> Attenuation Limits Progression of <i>Braf<sup>V600E</sup></i> -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAF<sup>V600E</sup> Inhibitor PLX4720Minjing Zou, Essa Y Baitei, Huda A BinEssa, et al.
Clinical Endocrinology|June 2, 2011
A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotypeHussein Raef, Minjing Zou, Essa Y Baitei, et al.
Clinical Endocrinology|April 7, 2017
Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic ricketsAyla Guven, Roua A Al-Rijjal, Huda A BinEssa, et al.
Clinical Endocrinology|October 25, 2011
Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistanceAli S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 7, 2015
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1Minjing Zou, Essa Y Baitei, Roua A Al-Rijjal, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2018
Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid DyshormonogenesisMinjing Zou, Ali S Alzahrani, Ali Al-Odaib, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Pageof 3